TRF Limited (BOM:505854)
232.95
+1.80 (0.78%)
At close: Aug 21, 2026
TRF Limited Revenue
In the fiscal year ending March 31, 2026, TRF Limited had annual revenue of 850.32M INR, down -29.57%. TRF Limited had revenue of 193.86M in the quarter ending March 31, 2026, a decrease of -28.49%.
Revenue
850.32M
Revenue Growth
-29.57%
P/S Ratio
3.01
Revenue / Employee
2.40M
Employees
354
Market Cap
2.56B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 850.32M | -357.03M | -29.57% |
| Mar 31, 2025 | 1.21B | -192.24M | -13.74% |
| Mar 31, 2024 | 1.40B | -371.43M | -20.97% |
| Mar 31, 2023 | 1.77B | 499.65M | 39.30% |
| Mar 31, 2022 | 1.27B | 131.88M | 11.57% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shree Ajit Pulp and Paper | 7.26B |
| Hindustan Organic Chemicals | 5.06B |
| Indo National | 4.48B |
| AION-TECH Solutions | 1.43B |
| Oxygenta Pharmaceutical | 1.35B |
| GRE Renew Enertech | 1.23B |
| Evexia Lifecare | 1.13B |
| Cosmo Ferrites | 1.01B |